Epicore Biosystems
Developed a proprietary sweat microfluidic sensor to improve health and drive athletic performance.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $6.0m Valuation: $130m | Series B | |
| Total Funding | 000k | ||
Related Content
Epicore Biosystems, Inc. specializes in developing innovative wearable microfluidic solutions that non-invasively measure sweat biomarkers, skin health, and physiology in real time. The company operates in the health and wellness market, focusing on athletes, clinical trials, and individuals with rare diseases. Its core product, the Gx Sweat Patch, developed in partnership with Gatorade and PepsiCo, is a skin-like wearable patch that pairs with a user-friendly software app to provide real-time, personalized hydration and performance recommendations. Epicore Biosystems generates revenue through the sale of its wearable devices and associated software services, targeting both individual consumers and institutional clients such as sports teams and healthcare providers.
Keywords: wearable sensors, sweat analysis, microfluidic technology, personalized tracking, hydration monitoring, athletic performance, skin health, real-time data, clinical trials, rare diseases.